Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Tagraxofusp | Elzonris | 4.4 Special warnings and precautions for use | Capillary leak syndrome, Hepatotoxicity | Jan, 2025 |
| Nifedipine | Adalat | 4.5 Interaction with other medicinal products and other forms of interaction | Antiarrhythmics,Calcium Channel Blockers,Angiotensin-II Blockers,Beta-blockers | Jan, 2025 |
| Moxifloxacin | Avalox | 4.5. Interactions with other medicinal products | Interactions with Warfarin, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Atenolol | Dec, 2024 |
| Guanfacine hydrochloride | Intuniv | 4.4 Special Warnings and Special Precautions for Use. 4.8 Undesirable effects | Aggression | Dec, 2024 |
| Sacitizumab Govitecan | Trodelvy | 4.8 Undesirable effects | Venous thromboembolism, alanine aminotransferase increased, aspartate aminotransferase increased | Dec, 2024 |
| Tisagenlecleucel | Kymriah | 4.4 Special Warnings and Special Precautions for Use | Risk of T cell malignancies | Dec, 2024 |